18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis

Arch Cardiovasc Dis. 2022 Feb;115(2):114-116. doi: 10.1016/j.acvd.2021.12.001. Epub 2022 Feb 1.
No abstract available

Keywords: Cardio-oncology; Cardiotoxicity; Immune checkpoint inhibitor myocarditis; Immunothérapie; Myocardite; PET-FDG; Pharmacologie.

Publication types

  • Letter

MeSH terms

  • Fluorodeoxyglucose F18*
  • Humans
  • Immune Checkpoint Inhibitors
  • Myocarditis* / chemically induced
  • Myocarditis* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals

Substances

  • Immune Checkpoint Inhibitors
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18